8-119731990-C-CT

Variant summary

Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2

The NM_003184.4(TAF2):​c.3533dupA​(p.Glu1179fs) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,882 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 6.8e-7 ( 0 hom. )

Consequence

TAF2
NM_003184.4 frameshift

Scores

Not classified

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.32
Variant links:
Genes affected
TAF2 (HGNC:11536): (TATA-box binding protein associated factor 2) Initiation of transcription by RNA polymerase II requires the activities of more than 70 polypeptides. The protein that coordinates these activities is transcription factor IID (TFIID), which binds to the core promoter to position the polymerase properly, serves as the scaffold for assembly of the remainder of the transcription complex, and acts as a channel for regulatory signals. TFIID is composed of the TATA-binding protein (TBP) and a group of evolutionarily conserved proteins known as TBP-associated factors or TAFs. TAFs may participate in basal transcription, serve as coactivators, function in promoter recognition or modify general transcription factors (GTFs) to facilitate complex assembly and transcription initiation. This gene encodes one of the larger subunits of TFIID that is stably associated with the TFIID complex. It contributes to interactions at and downstream of the transcription initiation site, interactions that help determine transcription complex response to activators. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
TAF2NM_003184.4 linkc.3533dupA p.Glu1179fs frameshift_variant 26/26 ENST00000378164.7 NP_003175.2 Q6P1X5B3KMD8

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
TAF2ENST00000378164.7 linkc.3533dupA p.Glu1179fs frameshift_variant 26/261 NM_003184.4 ENSP00000367406.2 Q6P1X5
TAF2ENST00000686879.1 linkc.3689dupA p.Glu1231fs frameshift_variant 27/27 ENSP00000509206.1 A0A8I5KV60
TAF2ENST00000685235.1 linkc.3578dupA p.Glu1194fs frameshift_variant 26/26 ENSP00000510174.1 A0A8I5QJR0
TAF2ENST00000688645.1 linkc.3422dupA p.Glu1142fs frameshift_variant 25/25 ENSP00000509978.1 A0A8I5KSY6
TAF2ENST00000523904.2 linkc.3419dupA p.Glu1141fs frameshift_variant 25/253 ENSP00000430832.2 H0YC37
TAF2ENST00000690144 linkc.*664dupA 3_prime_UTR_variant 26/26 ENSP00000510548.1 A0A8I5KUQ2
TAF2ENST00000685202.1 linkn.*1058dupA non_coding_transcript_exon_variant 27/27 ENSP00000509214.1 A0A8I5QJD7
TAF2ENST00000685503.1 linkn.*2925dupA non_coding_transcript_exon_variant 26/26 ENSP00000509198.1 A0A8I5KXS3
TAF2ENST00000685663.1 linkn.*3405dupA non_coding_transcript_exon_variant 28/28 ENSP00000508988.1 A0A8I5KUD2
TAF2ENST00000685684.1 linkn.*5000dupA non_coding_transcript_exon_variant 25/25 ENSP00000509441.1 A0A8I5KY57
TAF2ENST00000685824.1 linkn.*3234dupA non_coding_transcript_exon_variant 24/24 ENSP00000510262.1 A0A8I5KU60
TAF2ENST00000685876.1 linkn.*3251dupA non_coding_transcript_exon_variant 27/27 ENSP00000510493.1 A0A8I5KUD2
TAF2ENST00000685993.1 linkn.*3348dupA non_coding_transcript_exon_variant 25/25 ENSP00000510102.1 A0A8I5KU60
TAF2ENST00000686098.1 linkn.*2178dupA non_coding_transcript_exon_variant 25/25 ENSP00000509102.1 A0A8I5KXP3
TAF2ENST00000688037.1 linkn.*2952dupA non_coding_transcript_exon_variant 23/23 ENSP00000510169.1 A0A8I5KRI4
TAF2ENST00000689919.1 linkn.*3140dupA non_coding_transcript_exon_variant 26/26 ENSP00000510768.1 A0A8I5KUD2
TAF2ENST00000690808.1 linkn.*2769dupA non_coding_transcript_exon_variant 26/26 ENSP00000509791.1 A0A8I5KVC1
TAF2ENST00000690922.1 linkn.*1945dupA non_coding_transcript_exon_variant 26/26 ENSP00000509498.1 A0A8I5KPW0
TAF2ENST00000691880.1 linkn.*3189dupA non_coding_transcript_exon_variant 25/25 ENSP00000508515.1 A0A8I5KNG3
TAF2ENST00000692518.1 linkn.*3399dupA non_coding_transcript_exon_variant 25/25 ENSP00000508959.1 A0A8I5KU60
TAF2ENST00000692707.1 linkn.*3401dupA non_coding_transcript_exon_variant 28/28 ENSP00000509024.1 A0A8I5KUD2
TAF2ENST00000692916.1 linkn.*2920dupA non_coding_transcript_exon_variant 25/25 ENSP00000509603.1 A0A8I5QJI9
TAF2ENST00000685202.1 linkn.*1058dupA 3_prime_UTR_variant 27/27 ENSP00000509214.1 A0A8I5QJD7
TAF2ENST00000685503.1 linkn.*2925dupA 3_prime_UTR_variant 26/26 ENSP00000509198.1 A0A8I5KXS3
TAF2ENST00000685663.1 linkn.*3405dupA 3_prime_UTR_variant 28/28 ENSP00000508988.1 A0A8I5KUD2
TAF2ENST00000685684.1 linkn.*5000dupA 3_prime_UTR_variant 25/25 ENSP00000509441.1 A0A8I5KY57
TAF2ENST00000685824.1 linkn.*3234dupA 3_prime_UTR_variant 24/24 ENSP00000510262.1 A0A8I5KU60
TAF2ENST00000685876.1 linkn.*3251dupA 3_prime_UTR_variant 27/27 ENSP00000510493.1 A0A8I5KUD2
TAF2ENST00000685993.1 linkn.*3348dupA 3_prime_UTR_variant 25/25 ENSP00000510102.1 A0A8I5KU60
TAF2ENST00000686098.1 linkn.*2178dupA 3_prime_UTR_variant 25/25 ENSP00000509102.1 A0A8I5KXP3
TAF2ENST00000688037.1 linkn.*2952dupA 3_prime_UTR_variant 23/23 ENSP00000510169.1 A0A8I5KRI4
TAF2ENST00000689919.1 linkn.*3140dupA 3_prime_UTR_variant 26/26 ENSP00000510768.1 A0A8I5KUD2
TAF2ENST00000690808.1 linkn.*2769dupA 3_prime_UTR_variant 26/26 ENSP00000509791.1 A0A8I5KVC1
TAF2ENST00000690922.1 linkn.*1945dupA 3_prime_UTR_variant 26/26 ENSP00000509498.1 A0A8I5KPW0
TAF2ENST00000691880.1 linkn.*3189dupA 3_prime_UTR_variant 25/25 ENSP00000508515.1 A0A8I5KNG3
TAF2ENST00000692518.1 linkn.*3399dupA 3_prime_UTR_variant 25/25 ENSP00000508959.1 A0A8I5KU60
TAF2ENST00000692707.1 linkn.*3401dupA 3_prime_UTR_variant 28/28 ENSP00000509024.1 A0A8I5KUD2
TAF2ENST00000692916.1 linkn.*2920dupA 3_prime_UTR_variant 25/25 ENSP00000509603.1 A0A8I5QJI9

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
AF:
6.84e-7
AC:
1
AN:
1461882
Hom.:
0
Cov.:
31
AF XY:
0.00000138
AC XY:
1
AN XY:
727242
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
8.99e-7
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
33

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpSep 01, 2022In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant has not been reported in the literature in individuals affected with TAF2-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change results in a frameshift in the TAF2 gene (p.Glu1179Glyfs*40). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 21 amino acid(s) of the TAF2 protein and extend the protein by 18 additional amino acid residues. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr8-120744230; API